Ercole DiMartino

FDG—a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer

Michael Zimny, Bernd Gagel, Ercole DiMartino et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 129 citations

Positron Emission Tomography, Nuclear Medicine, Neck Cancer +14

pO2 Polarography Versus Positron Emission Tomography ([18F] Fluoromisonidazole, [18F]-2-Fluoro-2’-Deoxyglucose)

Bernd Gagel, Patrick Reinartz, Ercole DiMartino et al. · Strahlentherapie und Onkologie · 2004 · 111 citations

Positron Emission Tomography, Engineering, Novel Imaging Method +6

pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?

Bernd Gagel, Marc D. Piroth, Michael Pinkawa et al. · BMC Cancer · 2007 · 72 citations · Full text

Functional MR imaging of the Eustachian tube in patients with clinically proven dysfunction: correlation with lesions detected on MR images

Anna Lükens, Ercole DiMartino, Rolf W. Günther et al. · European Radiology · 2011 · 26 citations

Imaging Anatomy, Neuroimaging Modality, Medical Imaging +13